Anti-PD-1 therapy can possibly reverse CAR T cells exhaustion in DLBCL
Br J Haematol
.
2023 Jul;202(2):217-218.
doi: 10.1111/bjh.18797.
Epub 2023 Apr 4.
Authors
Sylvain Lamure
1
2
,
Charles Herbaux
1
3
Affiliations
1
Département d'Hématologie Clinique, CHU de Montpellier, Montpellier, France.
2
Hematopoiesis and Immunotherapy, Institut de Génétique Moléculaire de Montpellier, Université de Montpellier, Montpellier, France.
3
Laboratory for monitoring Innovative Therapies, Institut de Génétique Humaine, Université de Montpellier, Montpellier, France.
PMID:
37013670
DOI:
10.1111/bjh.18797
No abstract available
Keywords:
CAR T cells; diffuse large B cell lymphoma; immune checkpoint inhibitor.
Publication types
Comment
MeSH terms
Humans
Lymphoma, Large B-Cell, Diffuse* / drug therapy
T-Lymphocytes*